Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine vs. Olanzapine for negative symptoms of schizophrenia
NCT00212836Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in schizophrenia, sponsored by Organon & Co.. Started Apr 2005; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00212836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212836.